AUSTIN, Texas– Curative Inc., a leading health services company that recently launched a new health plan in the Austin area, has promoted Chief Financial Officer Tami Wilson-Ciranna, to President of the company, effective immediately. Wilson-Ciranna has a great depth of financial leadership experience in a variety of industries with a focus on high-growth companies. She joined Curative in April 2020 shortly after its pivot into COVID-19 testing, and her financial leadership experience was critical to Curative’s accelerated, but controlled, growth.
At Curative Insurance Company, Wilson-Ciranna will play a crucial role in leading the company’s growth and expansion, building on its success and taking it to new heights. Wilson-Ciranna’s responsibilities will include oversight of Finance, Legal, Pharmacy Operations and Formulary, Risk and Investment Management, Facilities, Accounting/Tax, Human Resources, and overall company strategy. She will also sit on the Board of Curative Insurance Company.
“Tami has been a crucial member of our C-Suite team since she joined Curative, and instrumental in the founding and launching of Curative Insurance Company,” said Fred Turner, CEO and co-founder of Curative. “We are thrilled to have her serve as President, bringing her strong financial knowledge and insights to the company. Tami’s qualifications and success at Curative made her a natural choice for this promotion. Her appointment represents a major milestone for the company and we are excited to see her in this new role.”
Wilson-Ciranna holds a CPA and obtained her MBA from the University of California – Los Angeles. She has experience raising debt & equity, mergers & acquisitions, reengineering, strategy execution, private equity, and high-growth companies. She has worked in a variety of industries including Biotech, Manufacturing, Real Estate, and Energy. In addition to her extensive business background, she has also been involved in COVID-19 response efforts. She served as Chief Financial Officer for Curative Labs Inc. during the pandemic response that provided over 36 million tests around the United States, providing financial and operational expertise to help the nation manage its response efforts.
Wilson-Ciranna previously served as the Chief Financial and Administrative Officer at Prolacta Bioscience, a company that produces human milk-based nutritional products for premature infants. During her tenure, she led the financial and operational growth of the company into profitability and oversaw successful capital and debt raises, construction of a state-of-the-art human milk processing facility, and implemented numerous upgrades in the technology department. In addition, she has more than 20 years of management experience, including nine years serving as the Chief Financial Officer of CommonWealth Partners, a vertically integrated real estate company that develops, owns, and manages Class A office space as an Investment Manager for CalPERS. Wilson-Ciranna was responsible for obtaining $500 million of debt on flexible terms, negotiating purchase and sale agreements, and overseeing improvements in IT. She also assisted in obtaining an investment partner and designing a reorganization plan.
